Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV002722502 | SCV003554639 | uncertain significance | Inborn genetic diseases | 2021-01-29 | criteria provided, single submitter | clinical testing | The c.1771A>T (p.I591F) alteration is located in exon 9 (coding exon 9) of the TUBGCP6 gene. This alteration results from a A to T substitution at nucleotide position 1771, causing the isoleucine (I) at amino acid position 591 to be replaced by a phenylalanine (F). The p.I591F alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |